Skip to content

Radiofrequency-assisted Transection of the Pancreas vs Stapler

Radiofrequency-assisted Transection of the Pancreas vs Stapler. A Phase III Randomized Clinical Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04402346
Acronym
TRANSPAIRE
Enrollment
112
Registered
2020-05-26
Start date
2021-02-15
Completion date
2025-05-30
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas; Fistula

Keywords

Pancreas fistula, Distal pancreatectomy, Radiofrequency

Brief summary

Main objective: The main end-point of this study is to compare in a randomized clinical trial that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative pancreatic fistula (POPF) compared to the classical method of transection (stapler). As secondary end-points, other clinical and demographic variables of the patients will be evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct size, duration of intervention, type of tumor and quality of lymphatic resection). Methodology: Phase III prospective multicenter study in patients undergoing distal pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy for any cause in a multicenter setting will be included. A simple randomization of the participants to the RFA group or to the control group (stapler) will be carried out. The incidence of pancreatic fistula will be assessed as main variable; predictive multivariable models with multiple regression for quantitative variables, logistic regression for categorical variables and Cox regression for survival analyzes. In addition to histological study, molecular analysis of resection specimen and clinical and radiological follow-up with volumetry of necrosis in the area of post-pancreatectomy transection will be performed.

Interventions

PROCEDURERadiofrequency-assisted pancreas transection

Transection of the pancreas in distal pancreatectomy by applying a radio frequency device

PROCEDUREStapler assisted pancreas transection

Transection of the pancreas in distal pancreatectomy by applying a stapler device with/without seamguard

Sponsors

Patricia Sanchez Velazquez
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Solid or cystic, benign or malign pancreas neoplasms. * Patients undergoing a distal pancreatectomy, i.e pancreas transection beyond \> 2 cm from the SMV (assessed by computer tomography or RM) with or without splenectomy * Both open and laparoscopic approaches are valid.

Exclusion criteria

* Patients who required a pancreatectomy with transection at the level of the neck. * Non-intervention group: only stapler transection will be accepted, other pancreatic transection methods will be excluded. * Patients ASA≥IV * Absence of informed consent * Underage (\<18 years)

Design outcomes

Primary

MeasureTime frameDescription
Pancreas fistula90 days follow-upDefined by the updated 2016 ISGPF definition

Secondary

MeasureTime frameDescription
In-hospital MortalityIn-Hospital (30 days)30 days
Morbidity90 days follow-upIn terms of Clavien-Dindo and CCI classification

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026